Design and Development of an Intelligent Clinical Decision Support System Applied to the Evaluation of Breast Cancer Risk

• Type: Article in International Scientific Journal
• Date: 2022

Authors

Casal Guisande, M (Author) Other; Comesana Campos, A (Author) Other; Ines Dutra (Author) FCUP; Cerqueiro Pequeno, J (Author) Other; Bouza Rodriguez, JB (Author) Other

Journal

The Journal is awaiting validation by the Administrative Services.

Title: JOURNAL OF PERSONALIZED MEDICINE

Vol. 4

Final page: 169

ISSN: 2075-4426

Publisher: MDPI

Indexing

ISI Web of Knowledge - 14 Citations

Scopus - 20 Citations

Other information

Authenticus ID: P-00W-1FW

DOI: 10.3390/jpm12020169

Abstract (EN): Breast cancer is currently one of the main causes of death and tumoral diseases in women. Even if early diagnosis processes have evolved in the last years thanks to the popularization of mammogram tests, nowadays, it is still a challenge to have available reliable diagnosis systems that are exempt of variability in their interpretation. To this end, in this work, the design and development of an intelligent clinical decision support system to be used in the preventive diagnosis of breast cancer is presented, aiming both to improve the accuracy in the evaluation and to reduce its uncertainty. Through the integration of expert systems (based on Mamdani-type fuzzy-logic inference engines) deployed in cascade, exploratory factorial analysis, data augmentation approaches, and classification algorithms such as k-neighbors and bagged trees, the system is able to learn and to interpret the patient's medical-healthcare data, generating an alert level associated to the danger she has of suffering from cancer. For the system's initial performance tests, a software implementation of it has been built that was used in the diagnosis of a series of patients contained into a 130-cases database provided by the School of Medicine and Public Health of the University of Wisconsin-Madison, which has been also used to create the knowledge base. The obtained results, characterized as areas under the ROC curves of 0.95-0.97 and high success rates, highlight the huge diagnosis and preventive potential of the developed system, and they allow forecasting, even when a detailed and contrasted validation is still pending, its relevance and applicability within the clinical field.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 26